RxDoctor Payments Data

Debra Martin, NP

Family · Ashland, KYNPI 1760733349

Payments from drug & device makers

$3,136in general payments, 2019–2025

Across 185 payments — averaging $16.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Merck$769
  • Novartis$625
  • Pfizer$287
  • AstraZeneca$287
  • Boehringer Ingelheim$227
  • ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$205
  • plus $735 from 13 others

What the payments were for

  • Food & beverage$3,125100%
  • Education$110%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,136 in reported general payments places this provider in the 85th percentile of 4,374 family providers in Kentucky.

See all family providers in Kentucky

Medicare billing

Part B allowed, 2024
$31,384
Medicare patients
187
Services billed
455

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EntrestoSacubitril/Valsartan98$100,334
JardianceEmpagliflozin74$92,788
FarxigaDapagliflozin Propanediol50$36,488
Potassium Chloride272$6,557
Bumetanide88$3,058
Metoprolol Succinate123$1,299
Furosemide259$1,162
Spironolactone84$856
Torsemide29$623
Midodrine Hcl13$568
Klor-Con M20Potassium Chloride13$303
Carvedilol88$298
Metolazone45$200
Isosorbide Mononitrate ErIsosorbide Mononitrate19$180
Hydralazine Hcl15$167

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
NovartisEntresto$625$100,33498 claims
Boehringer IngelheimJardiance$227$92,78874 claims
AstraZenecaFarxiga$287$36,48850 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 4,374 family providers in Kentucky.

Other family in Ashland

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →